PharmacoEpidemiology and Drug Safety (PharmaSafe)
Medications are an essential aspect of health care. The PharmacoEpidemiology & Drug Safety Research Group (PharmaSafe) covers a wide range of research activities related to optimal use and safety of medication on an individual and societal level. We use epidemiological methods to address questions of drug safety that cannot be studies in randomized controlled trials (RCTs). Our work includes monitoring of drug utilization in pregnancy, perception towards medicines, methodology research, analysis of medication safety on patient outcomes and health economics.
The research group is multidiciplinary and has expertise in pharmacoepidemiology and drug safety, biostatistics, health economics and pharmacotherapy.
Debate contribution in Aftenposten
Feb. 5, 2019 1:51 PM
Read the debate contribution in Aftenposten by PhD student Anette Vik Jøsendal: "Er dette en snikinnføring av alle barn i en nasjonal DNA-bank?"
Young Researh Talent Grant
Jan. 31, 2019 11:18 AM
Congratulations to our talented postdoc Angela Lupattelli with a Young Research Talent Grant from The Research Council of Norway!
Travel grants from Norsk Farmasøytisk Selskap (NFS) and UiO:LifeScience
Jan. 10, 2019 11:38 AM
Three PharmaSafe PhD students have received travel grants from NFS and UiO:LifeScience. Congratulations!
PharmaSafe PhD student presents at research symposium in Copenhagen
Dec. 4, 2018 1:58 PM
PhD student Sarah Hjorth Andersen presented her PhD at a research symposium in Copenhagen on November 30 th 2018.
Prof. Nordeng appointed by European Commission as independent scientific expert in PRAC
Dec. 4, 2018 1:53 PM
The Pharmacovigilance Risk Assessment Committee (PRAC) is the European Medicines Agency's (EMA) committee responsible for assessing and monitoring the safety of human medicines.